Averhealth Acquires Aspenti Health
Share this article
Share this article
RICHMOND, Va., May 19, 2021 /PRNewswire/ On May 17, 2021, Averhealth, a provider of substance use monitoring and treatment services tailored to the unique needs of courts and social service agencies, along with the support of Five Arrows Capital Partners, acquired Aspenti, a healthcare company located in Burlington, Vermont. Aspenti specializes in substance use monitoring and care coordination services for patients of physicians, treatment centers and healthcare systems. The acquisition of Aspenti broadens Averhealth s referral base to include physicians, treatment centers and healthcare systems. Aspenti s social mission of promoting positive change, improving well-being and creating a better world perfectly aligns with Averhealth s mission of reclaiming lives, uniting families and strengthening communities. This is a perfect fit for us as we advance our goal of improving patient outcomes for those st
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive access to available records for over 1,000 option and evaluation deals, including contract documents where available.
This report provides details of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of option and evaluation agreements from 2014 to 2021.
There are two major forms of deal term that allow a party to a deal to secure rights to an asset subject to a future event namely, option and evaluation.
Encision Reports Fourth Quarter Fiscal Year 2021 Results
News provided by
Share this article
Share this article
BOULDER, Colo., May 19, 2021 /PRNewswire/ Encision Inc. (PK: ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2021 fourth quarter that ended March 31, 2021.
The Company posted quarterly net revenue of $2.15 million for a quarterly net income of $116 thousand, or $0.01 per diluted share. These results compare to net revenue of $1.78 million for a quarterly net loss of $116 thousand, or $(0.01) per diluted share, in the year-ago quarter. Gross margin on net revenue was 54% in the fiscal 2021 fourth quarter and 53% in the fiscal 2020 fourth quarter.
Medical Guardian Welcomes New Chief Financial Officer to Growing Team
Top Philadelphia-area Finance Executive Mark Gaudiosi has joined the Medical Guardian Team as CFO.
News provided by
Share this article
Share this article
PHILADELPHIA, May 19, 2021 /PRNewswire/ Over the last 3 years, Mark was the Chief Financial Officer at
GoPuff where he built a world-class program that scaled enterprise value over 3500% by focusing on profitability and strategic acquisitions, valued at $8.9B after its most recent funding round. Mark s addition will help set a foundation that will support
Medical Guardian s growth into the healthcare sphere, while expanding and improving upon its existing product and services line. Mark also has years of experience leading finance and accounting initiatives at notable Philadelphia companies including
/PRNewswire/ Pieces, a healthcare AI company, announced today that Catholic Charities of Pueblo has chosen Pieces Connect,, its industry-leading community.